Member Log-in

I forgot my password

Not a Member? Register

Resources

Our resource library is a searchable collection of tools and documents relevant to various technical areas around the Gavi transition. The library consists of research articles, policy briefs, reports, guidebooks, country data, and other resources pertinent to Gavi transition or immunization programs generally. Some resources are available to LNCT members only and will require logging in to view.

Results 61 - 70 of 81

Estimated Economic Impact of Vaccinations in 73 Low- and Middle-income Countries, 2001-2020

Objective: To estimate the economic impact likely to be achieved by efforts to vaccinate against 10 vaccine-preventable diseases between 2001 and 2020 in 73 low- and middle-income countries largely supported by Gavi, the Vaccine Alliance. Methods: We used health impact models to estimate the economic impact of achieving forecasted coverages for vaccination against Haemophilus influenzae type b, … Continued

Download
File size: 560.21K

Principles and Considerations for Adding a Vaccine to a National Immunization Programme

This resource document reviews considerations for planning and implementing the introduction of a vaccine into a national immunization program. The document also highlights ways to use the opportunity provided by the vaccine introduction to strengthen immunization and health systems, and offers a list of relevant references and tools.  

Overcoming Challenges to Sustainable Immunization Financing

Sixteen countries are currently scheduled to ‘graduate’ from GAVI assistance by 2018. Five of these countries were chosen for ‘transition planning’ support from GAVI and other partners in 2012. Through country assessments, a variety of challenges were identified in transitioning away from GAVI assistance towards national self-sufficiency, including concerns relating to financial sustainability, sound procurement … Continued

Download
File size: 172.53K

Vaccination Legislation in Latin America and the Caribbean

Governments have the authority and responsibility to ensure vaccination for all citizens. The development of vaccination legislation in Latin America and the Caribbean (LAC) parallels the emergence of sustainable, relatively autonomous, and effective national immunization programs. We reviewed vaccination legislation and related legal documents from LAC countries (excluding Canada, Puerto Rico, the United States, and … Continued

New Vaccine Adoption in Lower-middle-income Countries

Lower-middle-income countries (LMICs) are lagging behind both high-income and low-income countries in new vaccine adoption. This study involved the following objectives: (1) understand the decision-making processes of LMICs on new vaccine adoption, (2) identify the factors influencing LMIC decisions, (3) obtain the views of vaccine manufacturers about LMIC markets for new vaccines, and (4) make recommendations concerning how to speed up and improve decision making, including proposing mechanisms for implementation of the recommendations,

An Analysis Of How The GAVI Alliance And Low- And Middle-Income Countries Can Share Costs Of New Vaccines

Immunization is one of the “best buys” in global health. However, for the poorest countries, even modest expenditures may be out of reach. The GAVI Alliance is a public-private partnership created to help the poorest countries introduce new vaccines. Since 2008 GAVI has required that countries cover a share of the cost of vaccines introduced … Continued

Download
File size: 381.54K

Sustaining GAVI-supported Vaccine Introductions in Resource-poor Countries

Since 2000, GAVI provided essential support for an unprecedented increase in the use of hepatitis B (HepB) and Haemophilus influenzae (Hib) containing vaccines in resource poor countries. This increase was supported with significant funding from international donors, intended to be time-limited. To assess the sustainability of this important expansion of the global access to vaccines, the authors of this article reviewed supply chains, financial resources for procurement and decision-making in countries that introduced hepatitis B or Hib vaccines with GAVI support.

Choose a Language